Delivery Order SPE2DB22D9316-SPE2DB25FYN28

Award Date 2/6/25
Potential Completion Date 2/28/25
Potential Value $17K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,694.56 firm fixed-price delivery order is for the supply of NPLATE 250 MCG VIALS, a specialized pharmaceutical product. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC enables the DLA...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,083.68 contract is for the delivery of NPLATE 250 MCG VIALS, a specialized pharmaceutical product. This award is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at $499,999,999, which allows the DLA to issue delivery orders for a...
This federal contract award, valued at $3,347.34, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of NPLATE 250 MCG VIALS, a specialized pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, valued at...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,694.68 contract is for the delivery of NPLATE 250 MCG VIALS, a specialized pharmaceutical product, with a period of performance through January 22, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
This federal contract award, valued at $1,673.67, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award is a firm fixed-price delivery order for NPLATE 250 MCG VIALS, a specialized pharmaceutical product. The contract has an ultimate completion date of February 18, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $3,389.12, is for the delivery of NPLATE 250 MCG VIALS, a pharmaceutical product, to support the recurring medical supply needs of military health facilities. The contract is a firm fixed-price delivery order with no set-aside designation, leveraging DMS Pharmaceutical...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is valued at $16,742.65 and has an ultimate completion date of February 6, 2025. It covers the delivery of NPLATE 500 MCG VIALS, a specialized pharmaceutical product, to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group Inc. is a key supplier in the...
This federal contract award from the Defense Logistics Agency (DLA) was issued to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $8,472.80, is a firm fixed-price delivery order for the provision of NPLATE 250 MCG VIALS, a specialized pharmaceutical product. The contract has an ultimate completion date of January 13, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by DMS...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $15,096.04, is for the delivery of NPLATE 250 MCG VIALS and does not have a set-aside designation. DMS Pharmaceutical Group Inc. holds a larger single-award indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,694.56 contract is for the delivery of NPLATE 250 MCG vials, a specialized pharmaceutical product, to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers. The contract is not associated with a specific set-aside designation,...
  • SPE2DB22D9316
    Indefinite Delivery Contract
  • SPE2DB22D9316-SPE2DB25FYN28
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The award, valued at $16,736.70, is for the supply of NPLATE 250 MCG VIALS, a specialized pharmaceutical product.

The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide.

The contract does not have a set-aside designation, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure direct federal awards across multiple product categories and medical domains. Through this and other contract awards, DMS Pharmaceutical Group has demonstrated its capability to provide a diverse array of pharmaceutical products to the DLA and support the recurring medical supply needs of military healthcare facilities and veterans' medical centers nationwide.

Generated 5/8/25, 9:44 AM